Latest news
Loading news…
Genkyotex develops innovative drugs to block the NOX enzymes that produce oxygen radicals.
Genkyotex was acquired by Calliditas Therapeutics in 2020 for $20M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Geneva, Geneve, Switzerland
Acquisitions by Genkyotex
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Genkyotex
Head of Screening and Biotechnology
Board Observers
1
professional contacts at Genkyotex
Contact execs at Genkyotex →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Genkyotex
Loading news…
FAQs about Genkyotex
People who checked this page also checked these
Sectors Genkyotex invests & acquires in
Browse the full Acquirezy directory.